If successful, the vaccine could protect women against ovarian cancer, which only around half of women survive long-term at the moment.

Scientists at the University of Oxford have just received funding to create the world's first vaccine for ovarian cancer, a deadly disease that affects thousands of people each year. The vaccine, called OvarianVax,

Researchers at MUSC Hollings Cancer Center say that in the course of developing a new model for ovarian cancer, they’ve developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes,

In this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognized by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.

The world’s first ovarian cancer vaccine has been awarded research funding in the United Kingdom, marking the first step toward a groundbreaking preventive measure that scientists say could eliminate the disease entirely.

A first-ever ovarian cancer vaccine – currently being developed by the University of Oxford hopes to wipe off the deadly cancer – which kills thousands of women across the world yearly. According to scientists – the jab could be given to all women preventatively to eliminate the disease,